
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health is forecasted to see strong growth in 2026 based on its solid core growth rate, with the company expecting to see 21%-31% growth, excluding the impact of a $55 million CID and a $15 million inventory benefit headwind. This growth potential, combined with the company's current share price weakness, presents an excellent buying opportunity for investors with a long-term horizon. With risks in both directions, including potential competition and slower growth in specialty and utilization, thorough analysis and evaluation of the factors that are material to the company's ESG performance are crucial for establishing an accurate price target.
Bears say
Option Care Health is facing numerous challenges, including weaker-than-expected top-line performance due to unexpected headwinds in certain drug categories and high operating expenses. While the company has identified potential areas for cost savings and expects to see increased revenue in the second half of 2026, it is uncertain if these efforts will be enough to achieve its optimistic financial guidance. Additionally, the company holds a significant amount of debt and has been using a large portion of its cash flow for share buybacks, raising concerns about its financial stability and ability to invest in future growth opportunities.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares